Search

Nathaniel Herzfeld

Examiner (ID: 2727, Phone: (571)272-5899 , Office: P/3749 )

Most Active Art Unit
3762
Art Unit(s)
3743, 3749, 3762
Total Applications
626
Issued Applications
427
Pending Applications
1
Abandoned Applications
203

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10782921 [patent_doc_number] => 20160129077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanoma' [patent_app_type] => utility [patent_app_number] => 14/907263 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7107 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907263 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/907263
Use of recombinant ganoderma immunoregulatory protein (rLZ-8) in preparation of drug for treating melanoma Jun 12, 2014 Abandoned
Array ( [id] => 10776233 [patent_doc_number] => 20160122389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'PEPTIDES WITH ANTAGONISTIC ACTIVITIES AGAINST NATURAL CXCR4' [patent_app_type] => utility [patent_app_number] => 14/896249 [patent_app_country] => US [patent_app_date] => 2014-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9865 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896249 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/896249
Peptides with antagonistic activities against natural CXCR4 Jun 11, 2014 Issued
Array ( [id] => 14360683 [patent_doc_number] => 10301629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides [patent_app_type] => utility [patent_app_number] => 14/897450 [patent_app_country] => US [patent_app_date] => 2014-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 25 [patent_no_of_words] => 39069 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897450 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/897450
Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides Jun 10, 2014 Issued
Array ( [id] => 11053371 [patent_doc_number] => 20160250333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'SUBCUTANEOUS INJECTION PREPARATION FOR INDUCING BOVINE SUPEROVULATION' [patent_app_type] => utility [patent_app_number] => 14/907165 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4463 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14907165 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/907165
Subcutaneous injection product for cattle for inducing superovulation May 22, 2014 Issued
Array ( [id] => 9720934 [patent_doc_number] => 20140256634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'Treatments for Gastrointestinal Disorders' [patent_app_type] => utility [patent_app_number] => 14/286145 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16070 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14286145 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/286145
Treatments for Gastrointestinal Disorders May 22, 2014 Abandoned
Array ( [id] => 10729616 [patent_doc_number] => 20160075765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'MODIFIED COLLAGEN MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/890037 [patent_app_country] => US [patent_app_date] => 2014-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 14616 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890037 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/890037
MODIFIED COLLAGEN MOLECULES May 8, 2014 Abandoned
Array ( [id] => 9838538 [patent_doc_number] => 20150030618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/269577 [patent_app_country] => US [patent_app_date] => 2014-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122648 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14269577 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/269577
NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF May 4, 2014 Abandoned
Array ( [id] => 12165328 [patent_doc_number] => 09884087 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-02-06 [patent_title] => 'Compositions and methods of improved wound healing' [patent_app_type] => utility [patent_app_number] => 14/270193 [patent_app_country] => US [patent_app_date] => 2014-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 7586 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14270193 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/270193
Compositions and methods of improved wound healing May 4, 2014 Issued
Array ( [id] => 9670449 [patent_doc_number] => 20140234311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'ALBUMIN VARIANTS' [patent_app_type] => utility [patent_app_number] => 14/262244 [patent_app_country] => US [patent_app_date] => 2014-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 28935 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14262244 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/262244
ALBUMIN VARIANTS Apr 24, 2014 Abandoned
Array ( [id] => 11857955 [patent_doc_number] => 09737622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Compounds modulators of VEGF activity and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/259085 [patent_app_country] => US [patent_app_date] => 2014-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7377 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14259085 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/259085
Compounds modulators of VEGF activity and uses thereof Apr 21, 2014 Issued
Array ( [id] => 11230974 [patent_doc_number] => 09458194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 14/783689 [patent_app_country] => US [patent_app_date] => 2014-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23621 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14783689 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/783689
Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions Apr 14, 2014 Issued
Array ( [id] => 9910235 [patent_doc_number] => 20150065437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'AROMATIC-CATIONIC PEPTIDES AND USES OF SAME' [patent_app_type] => utility [patent_app_number] => 14/220974 [patent_app_country] => US [patent_app_date] => 2014-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 88 [patent_no_of_words] => 17622 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14220974 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/220974
AROMATIC-CATIONIC PEPTIDES AND USES OF SAME Mar 19, 2014 Abandoned
Array ( [id] => 9757565 [patent_doc_number] => 20140288266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'Synthesis of Cyclosporin Analogs' [patent_app_type] => utility [patent_app_number] => 14/217827 [patent_app_country] => US [patent_app_date] => 2014-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 26995 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14217827 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/217827
Synthesis of Cyclosporin Analogs Mar 17, 2014 Abandoned
Array ( [id] => 14391311 [patent_doc_number] => 10308926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-04 [patent_title] => Stablized EZH2 peptides [patent_app_type] => utility [patent_app_number] => 14/772143 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 50 [patent_no_of_words] => 20747 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772143 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/772143
Stablized EZH2 peptides Mar 12, 2014 Issued
Array ( [id] => 13127467 [patent_doc_number] => 10081654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Stapled and stitched polypeptides and uses thereof [patent_app_type] => utility [patent_app_number] => 14/775315 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 41616 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775315 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/775315
Stapled and stitched polypeptides and uses thereof Mar 12, 2014 Issued
Array ( [id] => 11907055 [patent_doc_number] => 09775853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Hemostatic compositions and methods' [patent_app_type] => utility [patent_app_number] => 14/209887 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5303 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209887 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/209887
Hemostatic compositions and methods Mar 12, 2014 Issued
Array ( [id] => 11814917 [patent_doc_number] => 09718858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-01 [patent_title] => 'Tunable control of protein degradation in synthetic and endogenous bacterial systems' [patent_app_type] => utility [patent_app_number] => 14/773937 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 43 [patent_no_of_words] => 41062 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773937 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/773937
Tunable control of protein degradation in synthetic and endogenous bacterial systems Mar 12, 2014 Issued
Array ( [id] => 10938985 [patent_doc_number] => 20140342006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'Methods for Preparing Injectable Protein Microparticle Suspensions' [patent_app_type] => utility [patent_app_number] => 14/209350 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2613 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14209350 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/209350
Methods for Preparing Injectable Protein Microparticle Suspensions Mar 12, 2014 Abandoned
Array ( [id] => 10649380 [patent_doc_number] => 09365616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Use of endostatin peptides for the treatment of fibrosis' [patent_app_type] => utility [patent_app_number] => 14/207246 [patent_app_country] => US [patent_app_date] => 2014-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 34 [patent_no_of_words] => 24691 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14207246 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/207246
Use of endostatin peptides for the treatment of fibrosis Mar 11, 2014 Issued
Array ( [id] => 10122499 [patent_doc_number] => 09156850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Enediyne compounds, conjugates thereof, and uses and methods therefor' [patent_app_type] => utility [patent_app_number] => 14/203118 [patent_app_country] => US [patent_app_date] => 2014-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 18992 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14203118 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/203118
Enediyne compounds, conjugates thereof, and uses and methods therefor Mar 9, 2014 Issued
Menu